Zebra Medical Vision Expands Its Footprint in North America and Appoints a New CEO

12:00 EST 14 Jan 2020 | Businesswire
Zebra Medical Vision

Zebra Medical Vision, the deep-learning medical imaging analytics company, announces today that Ohad Arazi has been appointed as Chief Executive Officer, succeeding Co-Founder Eyal Gura, who will continue as Chairman of the board. Mr Arazi brings to Zebra-Med extensive leadership experience in healthcare IT and medical imaging, along with a proven track record of driving transformative growth and building value at digital health firms, including McKesson Technology Solutions, Change Healthcare, and TELUS Health. Mr Arazi’s appointment is effective starting March 1, 2020.

This press release features multimedia. View the full release here:

(Photo: Business Wire)

(Photo: Business Wire)

“Ohad Arazi's appointment is a clear reflection of the strong vector the Zebra Medical Vision team has created, as we’re ready to take on the future after another strong year of product innovation, unique regulatory progress, and customer successes,” says Eyal Gura, Co-Founder and Chairman of the board. “Zebra-Med is poised for major expansion in the medical imaging domain, and we're confident that Ohad's unique experience in turning innovative technologies into scalable and impactful products will drive significant growth for us.”

“Every CEO dreams of being able to drive the evolution of a company from such a position of material strength. As we expand our footprint in North America, the breadth of Zebra-Med’s products and compelling regulatory advantage will allow us to scale extraordinarily fast,“ says Ohad Arazi. “I am thankful for the opportunity to lead one of the most exciting teams in healthcare today, and to leverage artificial intelligence to affect change for the medical imaging industry worldwide.”

With the 4th FDA clearance for its “all-in-one” AI1™ bundle, Zebra-Med provides a one-stop-shop for health providers’ AI needs. From oncology and bone health, through cardiology and acute conditions alerts, to the ICU and ED units. In Q4 of 2019 the company also branched into the orthopaedic space with a partnership with Depuy Synthes.

Read more on Zebra-Med’s blog:

About Zebra Medical Vision
Zebra Medical Vision's Imaging Analytics Platform allows healthcare institutions to identify patients at risk of disease and offer improved, preventative treatment pathways to improve patient care. Zebra-Med is funded by Khosla Ventures, Marc Benioff, Intermountain Investment Fund, OurCrowd Qure, Aurum, aMoon, Nvidia, J&J, Dolby Ventures and leading AI researchers Prof Fei Fei Le , Prof Amnon Shashua and Richard Shocher. Zebra Medical Vision has raised $52 million in funding to date, and was named a Fast Company Top-5 AI and Machine Learning company.

Alona Stein
Blonde 2.0 for Zebra Medical Vision


More From BioPortfolio on "Zebra Medical Vision Expands Its Footprint in North America and Appoints a New CEO"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...